Commands a premium valuation multiple over its peers, likely pricing in superior execution.
Moderate quality score of 57/100, reflecting stable operating margins and manageable leverage.
Analysts remain cautious, with consensus price targets indicating limited room for upside expansion.
Verdict: Average quality business weighed down by significant profitability concerns.
Wall Street is cautious, forecasting potential downside alongside robust expected earnings growth. The company currently dilutes shareholders to fund operations and growth rather than returning capital.
IPI struggles with subpar profitability and pressured margins. This is backed by a fortress balance sheet, holding significant net cash ($80M) and minimal debt risk.
The company is facing top-line contraction (-4.0% 3Y CAGR) however, earnings have severely contracted over the same period. Operating efficiency remains adequate with margins around 5.0%.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $98.7M | +17.1% | -4.0% | +8.7% | +0.4% | |
| EBITDA | $16.4M | — | -23.8% | — | — | |
| Net Income | $7.4M | +105.3% | -46.3% | — | — | |
| EPS (Diluted) | $0.56 | +105.1% | -45.9% | — | — | |
| Free Cash Flow | $18.0M | -24.0% | +8.3% | +11.7% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 18.5% | 14.0% | 20.9% | 13.8% |
| Operating Margin | 5.0% | -6.1% | 4.4% | -1.2% |
| Net Margin | 4.7% | -30.9% | 4.2% | -2.7% |
| FCF Margin | 13.7% | 4.6% | 8.4% | 4.3% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.48 | $0.62 | +29.2% | ||
| Q1'26 | $0.26 | $0.49 | +88.5% | ||
| Q4'25 | $0.13 | $0.11 | -15.4% | ||
| Q3'25 | $0.17 | $0.45 | +164.7% | ||
| Q2'25 | $-0.12 | $0.39 | +425.0% | ||
| Q1'25 | $-0.05 | $-0.11 | -120.0% | ||
| Q4'24 | $-0.13 | $-0.14 | -7.7% | ||
| Q3'24 | $-0.00 | $-0.06 | -1298.6% |
Total return is -8.7% (1Y), lagging the benchmark by -33.7%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +22.2% | +12.9% | — |
| 1Y | -8.7% | -33.7% | — |
| 3YCAGR | +17.6% | -1.3% | — |
| 5YCAGR | +4.0% | -8.5% | — |
| 10YCAGR | +8.6% | -5.1% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Intrepid Potash, Inc. (IPI) valuation, health, and returns.
Based on peer relative multiples, Intrepid Potash, Inc. appears Expensive versus peers compared to industry peers.
Intrepid Potash, Inc. has multiple valuation anchors: Peer Relative Fair Value: $22.31 | Wall Street Analyst Target: $26.00 (implying -24.6% upside). A convergence of these signals offers higher conviction.
Intrepid Potash, Inc. displays fair financial health with a composite quality score of 57/100, supported by a Altman Z-Score of 2.4 (grey zone), Piotroski F-Score of 7/9, Return on Invested Capital (ROIC) of 2.7%.
Intrepid Potash, Inc. does not return material capital to shareholders via dividends or share repurchases, electing to retain earnings to fund internal growth.
Intrepid Potash, Inc.'s current growth trajectory is Accelerating. The company achieved +17.1% 1Y revenue growth and +105.1% 1Y EPS growth, compared to its 3Y revenue CAGR of -4.0%.
Wall Street consensus is Hold based on 26 analysts, beating EPS expectations in 33% of recent quarters with a 2-quarter streak. The consensus price target represents a -24.6% change from current levels.
Investment risks for Intrepid Potash, Inc. include: -34.9% 1-year max drawdown. Volatility risk is characterized by a beta of 0.39x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.